Основная статистика
| LEI | 5493003ATO3H7ZMQGL06 |
| CIK | 1798270 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Assure Holdings Corp.
SEC Filings (Chronological Order)
На этой странице представлен полный хронологический список документов SEC, за исключением документов о собственности, которые мы предоставляем в других местах.
| January 22, 2025 |
Other Events, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 15, 2025 Assure Holdings Corp. (Name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission File Num |
|
| December 23, 2024 |
Settlement Agreement and Mutual Release Exhibit 10.1 Settlement Agreement and Mutual Release This Settlement Agreement and Mutual Release (“Agreement”) is made effective this 11th day of December, 2024 (the “Effective Date”), by and between Assure Holdings Corp. (“Assure”), Assure Acquisition Corp. (“Merger Sub”) and Wellgistics Health, Inc. formerly known as Danam Health, Inc. (“Danam”). The signatories to this Agreement will be referr |
|
| December 23, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 15, 2024 Assure Holdings Corp. (Name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| November 18, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One) ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: September 30, 2024 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transition Report o |
|
| October 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): September 13, 2024 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission |
|
| September 27, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-40785 ASS |
|
| September 27, 2024 |
Form of Subscription Agreements dated June 27, 2024 EXHIBIT 10.4 SUBSCRIPTION AGREEMENT ASSURE HOLDINGS CORP. This SUBSCRIPTION AGREEMENT (this “Agreement”), dated as of [●], 2024 is made by and between Assure Holdings Corp., a Nevada corporation (the “Company”), and [●] (the “Subscriber”). WHEREAS, the Company and the Subscriber has previously rendered services to the Company for value for which there is $[●] of trade accounts payable due and paya |
|
| September 27, 2024 |
EXHIBIT 10.5 Amended and Restated Memorandum of Understanding for Exchange Agreement This Binding Amended and Restated Memorandum of Understanding (“Agreement”) is entered into by and between Assure Holdings Corp. (the “Company”) and Centurion Financial Trust (the “Holder” and in its capacity as agent and nominee, the “Agent”) as of August 30, 2024, in amendment and restatement of that Memorandum |
|
| September 24, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (Amendment No. 10) Tender Offer Statement Under Section 13(e)(1) of the Securities Exchange Act of 1934 ASSURE HOLDINGS CORP. (Name of Subject Company (Issuer) and Filing Person (Offeror)) 9% CONVERTIBLE DEBENTURES DUE 2023 AND 2024 (Title of Class of Securities) 04625J303 (CUSIP Number of Common Stock Underlying D |
|
| September 24, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 20, 2024 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission |
|
| September 20, 2024 |
September 20, 2024 Via EDGAR Transmission United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N. |
|
| September 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (Amendment No. 9) Tender Offer Statement Under Section 13(e)(1) of the Securities Exchange Act of 1934 ASSURE HOLDINGS CORP. (Name of Subject Company (Issuer) and Filing Person (Offeror)) 9% CONVERTIBLE DEBENTURES DUE 2023 AND 2024 (Title of Class of Securities) 04625J303 (CUSIP Number of Common Stock Underlying De |
|
| September 9, 2024 |
Amendment No. 4 to Offer Letter dated September 7, 2024 Exhibit (a)(1)(v) AMENDMENT NO. 4 ASSURE HOLDINGS CORP. OFFER TO EXCHANGE SHARES OF COMMON STOCK FOR OUTSTANDING 9% CONVERTIBLE NOTES DUE 2023 AND 2024 ISSUED BY ASSURE HOLDINGS CORP. SEPTEMBER 7, 2024 THE CONVERTIBLE NOTE EXCHANGE OFFER WILL EXPIRE AT 11:59 P.M., DENVER TIME, ON SEPTEMBER 20, 2024 UNLESS EXTENDED (SUCH TIME AND DATE, AS IT MAY BE EXTENDED, THE “EXPIRATION DATE”). This Amendment N |
|
| September 9, 2024 |
Press Release dated September 7, 2024 Exhibit (a)(1)(xvi) Assure Announces Amendment of Exchange Offer Relating to its Convertible Notes Denver, September 7, 2024 – Assure Holdings Corp. |
|
| September 6, 2024 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 30, 2024 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission Fil |
|
| September 6, 2024 |
Amended and Restated Memorandum of Understanding with Centurion dated August 30, 2024 Exhibit 10.1 Amended and Restated Memorandum of Understanding for Exchange Agreement This Binding Amended and Restated Memorandum of Understanding (“Agreement”) is entered into by and between Assure Holdings Corp. (the “Company”) and Centurion Financial Trust (the “Holder” and in its capacity as agent and nominee, the “Agent”) as of August 30, 2024, in amendment and restatement of that Memor |
|
| August 26, 2024 |
Press Release dated August 26, 2024 Exhibit (a)(1)(xiv) Assure Announces Extension of Exchange Offer Relating to its Convertible Notes Denver, August 26, 2024 – Assure Holdings Corp. |
|
| August 26, 2024 |
SC TO-I/A 1 tm2422713d1sctoia.htm SC TO-I/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (Amendment No. 8) Tender Offer Statement Under Section 13(e)(1) of the Securities Exchange Act of 1934 ASSURE HOLDINGS CORP. (Name of Subject Company (Issuer) and Filing Person (Offeror)) 9% CONVERTIBLE DEBENTURES DUE 2023 AND 2024 (Title of Class of Securities) 04625J303 |
|
| August 20, 2024 |
Press Release dated August 19, 2024 Exhibit (a)(1)(xiii) Assure Announces Extension of Exchange Offer Relating to its Convertible Notes Denver, August 19, 2024 – Assure Holdings Corp. |
|
| August 20, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (Amendment No. 7) Tender Offer Statement Under Section 13(e)(1) of the Securities Exchange Act of 1934 ASSURE HOLDINGS CORP. (Name of Subject Company (Issuer) and Filing Person (Offeror)) 9% CONVERTIBLE DEBENTURES DUE 2023 AND 2024 (Title of Class of Securities) 04625J303 (CUSIP Number of Common Stock Underlying De |
|
| August 20, 2024 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 20, 2024 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission Fil |
|
| August 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One) ¨ Form 10-K ¨ Form 20-F ¨ Form 11-K x Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For Period Ended: June 30, 2024 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Report on Form 10-Q ¨ Transition Report on For |
|
| August 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 31, 2024 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission File |
|
| August 7, 2024 |
Purchase Agreement dated July 31, 2024 Exhibit 10.1 Equity Purchase Agreement This Equity Purchase Agreement (the “Agreement”) is made as of July 31, 2024 (the “Effective Date”), by and among 0915223 B.C. Ltd., a British Columbia corporation (the “Buyer”) located at 3529 Arbutus Street, Vancouver, B,C V6J 3Z6 and Assure Holdings Corp., a Nevada corporation (“Assure Parent”), Assure Holdings Inc., a Colorado corporation, Assure Neuromon |
|
| August 6, 2024 |
Press Release dated August 5, 2024 Exhibit (a)(1)(xii) Assure Announces Further Extension of Exchange Offer Relating to its Convertible Notes Denver, August 5, 2024 – Assure Holdings Corp. |
|
| August 6, 2024 |
Amendment No. 3 to Offer Letter dated July 30, 2024 Exhibit (a)(1)(iv) AMENDMENT NO. 3 ASSURE HOLDINGS CORP. OFFER TO EXCHANGE SHARES OF COMMON STOCK FOR OUTSTANDING 9% CONVERTIBLE NOTES DUE 2023 AND 2024 ISSUED BY ASSURE HOLDINGS CORP. AUGUST 5, 2024 THE CONVERTIBLE NOTE EXCHANGE OFFER WILL EXPIRE AT 11:59 P.M., DENVER TIME, ON AUGUST 16, 2024 UNLESS EXTENDED (SUCH TIME AND DATE, AS IT MAY BE EXTENDED, THE “EXPIRATION DATE”). This Amendment No. 3 |
|
| August 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (Amendment No. 6) Tender Offer Statement Under Section 13(e)(1) of the Securities Exchange Act of 1934 ASSURE HOLDINGS CORP. (Name of Subject Company (Issuer) and Filing Person (Offeror)) 9% CONVERTIBLE DEBENTURES DUE 2023 AND 2024 (Title of Class of Securities) 04625J303 (CUSIP Number of Common Stock Underlying De |
|
| July 30, 2024 |
Press Release dated July 29, 2024 Exhibit (a)(1)(x) Assure Announces Extension of Exchange Offer Relating to its Convertible Notes Denver, July 29, 2024 – Assure Holdings Corp. |
|
| July 30, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (Amendment No. 5) Tender Offer Statement Under Section 13(e)(1) of the Securities Exchange Act of 1934 ASSURE HOLDINGS CORP. (Name of Subject Company (Issuer) and Filing Person (Offeror)) 9% CONVERTIBLE DEBENTURES DUE 2023 AND 2024 (Title of Class of Securities) 04625J303 (CUSIP Number of Common Stock Underlying De |
|
| July 24, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 18, 2024 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission File |
|
| July 24, 2024 |
Memorandum of Understanding with Centurion Financial Trust dated July 18, 2024 Exhibit 10.1 Memorandum of Understanding for Exchange Agreement This Binding Memorandum of Understanding (“Agreement”) is entered into by and between Assure Holdings Corp. (the “Company”) and Centurion Financial Trust (the “Holder” and in its capacity as agent and nominee, the “Agent”) as of July 18, 2024. WHEREAS, on June 10, 2021, the Company entered into definitive agreements to secure a credit |
|
| July 23, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 17, 2024 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission File |
|
| July 22, 2024 |
Press Release dated July 22, 2024 Exhibit (a)(1)(ix) Assure Announces Extension of Exchange Offer Relating to its Convertible Notes Denver, July 22, 2024 – Assure Holdings Corp. |
|
| July 22, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (Amendment No. 4) Tender Offer Statement Under Section 13(e)(1) of the Securities Exchange Act of 1934 ASSURE HOLDINGS CORP. (Name of Subject Company (Issuer) and Filing Person (Offeror)) 9% CONVERTIBLE DEBENTURES DUE 2023 AND 2024 (Title of Class of Securities) 04625J303 (CUSIP Number of Common Stock Underlying De |
|
| July 18, 2024 |
Calculation for Filing Fee Table Exhibit 107 Calculation of Filing Fee Tables S-1 (Form Type) ASSURE HOLDINGS CORP. |
|
| July 18, 2024 |
Exhibit 4.7 LOCK-UP AGREEMENT , 2024 [ ], as placement agent in the Offering (as defined below) Re: Offering (as defined below) by Assure Holdings Corp. (the “Company”) Ladies and Gentlemen: The undersigned irrevocably agrees with the Company that, from the date hereof until sixty (60) days following the closing of the Company’s offering of registered securities pursuant to an effective registrati |
|
| July 18, 2024 |
Exhibit 4.4 PRE-FUNDED COMMON STOCK PURCHASE WARRANT ASSURE HOLDINGS CORP. Warrant Shares: Initial Exercise Date: , 2023 THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set f |
|
| July 18, 2024 |
Form of Securities Purchase Agreement Exhibit 10.29 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of July , 2024, between Assure Holdings Corp., a Nevada corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”). WHEREAS, subject to the terms and conditions set f |
|
| July 18, 2024 |
Exhibit 4.5 CLASS [A][B] COMMON STOCK PURCHASE WARRANT ASSURE HOLDINGS CORP. Warrant Shares: Issue Date: , 2024 THIS CLASS [A][B] COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the [the Shareholder |
|
| July 18, 2024 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 18, 2024 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission File |
|
| July 18, 2024 |
SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| July 18, 2024 |
Table of Contents As filed with the Securities and Exchange Commission on July 18, 2024 Registration No. |
|
| July 18, 2024 |
Form of Placement Agent Warrant Exhibit 4.6 PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT ASSURE HOLDINGS CORP. Warrant Shares: Issue Date: , 2024 THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the [the Shareh |
|
| July 18, 2024 |
Form of Subscription Agreement with holders of accounts payable Exhibit 10.28 SUBSCRIPTION AGREEMENT ASSURE HOLDINGS CORP. This SUBSCRIPTION AGREEMENT (this “Agreement”), dated as of , 2024, is made by and between Assure Holdings Corp., a Nevada corporation (the “Company”), and (the “Subscriber”). WHEREAS, the Subscriber has previously rendered services to the Company for value for which there is $73,675 of trade accounts payable due and payable to the Subscri |
|
| July 12, 2024 |
Amendment No. 2 to Offer Letter dated July 12, 2024 Exhibit (a)(1)(iii) AMENDMENT NO. 2 ASSURE HOLDINGS CORP. OFFER TO EXCHANGE SHARES OF COMMON STOCK FOR OUTSTANDING 9% CONVERTIBLE NOTES DUE 2023 AND 2024 ISSUED BY ASSURE HOLDINGS CORP. JULY 12, 2024 THE CONVERTIBLE NOTE EXCHANGE OFFER WILL EXPIRE AT 11:59 P.M., DENVER TIME, ON JULY 19, 2024 UNLESS EXTENDED (SUCH TIME AND DATE, AS IT MAY BE EXTENDED, THE “EXPIRATION DATE”). This Amendment No. 2 (t |
|
| July 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (Amendment No. 3) Tender Offer Statement Under Section 13(e)(1) of the Securities Exchange Act of 1934 ASSURE HOLDINGS CORP. (Name of Subject Company (Issuer) and Filing Person (Offeror)) 9% CONVERTIBLE DEBENTURES DUE 2023 AND 2024 (Title of Class of Securities) 04625J303 (CUSIP Number of Common Stock Underlying De |
|
| July 12, 2024 |
[ASSURE HOLDINGS CORP. LETTERHEAD] July 12, 2024 [ASSURE HOLDINGS CORP. LETTERHEAD] July 12, 2024 Division of Corporation Finance Office of Mergers & Acquisitions United States Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549-3561 Re: Assure Holdings Corp. Schedule TO-I/A filed July 3, 2024 File No. 005-92920 Ladies and Gentlemen: Set forth below are the responses of Assure Holdings Corp. (the “Company,” “we,” “us” or |
|
| July 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (Amendment No. 2) Tender Offer Statement Under Section 13(e)(1) of the Securities Exchange Act of 1934 ASSURE HOLDINGS CORP. (Name of Subject Company (Issuer) and Filing Person (Offeror)) 9% CONVERTIBLE DEBENTURES DUE 2023 AND 2024 (Title of Class of Securities) 04625J303 (CUSIP Number of Common Stock Underlying De |
|
| July 9, 2024 |
Letter to Holders dated July 9, 2024 Exhibit (a)(1)(vii) July 9, 2024 [ADDRESS] [EMAIL ADDRESS] Re: Offer to Exchange Convertible Notes for Shares of Common Stock Dear Holder: We are writing to inform you of important information relating to the Convertible Note Exchange Offer by Assure Holdings Corp. |
|
| July 9, 2024 |
Exhibit 3.1 Certified Copy 7/5/2024 12:52:40 PM Work Order Number: W2024070500713 Reference Number: 20244168171 Through Date: 7/5/2024 12:52:40 PM Corporate Name: ASSURE HOLDINGS CORP The undersigned filing officer hereby certifies that the attached copies are true and exact copies of all requested statements and related subsequent documentation filed with the Secretary of State’s Office, Commerci |
|
| July 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): July 5, 2024 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission File N |
|
| July 8, 2024 |
SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| July 3, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 27, 2024 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission File |
|
| July 3, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (Amendment No. 1) Tender Offer Statement Under Section 13(e)(1) of the Securities Exchange Act of 1934 ASSURE HOLDINGS CORP. (Name of Subject Company (Issuer) and Filing Person (Offeror)) 9% CONVERTIBLE DEBENTURES DUE 2023 AND 2024 (Title of Class of Securities) 04625J303 (CUSIP Number of Common Stock Underlying De |
|
| July 3, 2024 |
[ASSURE HOLDINGS CORP. LETTERHEAD] July 3, 2024 [ASSURE HOLDINGS CORP. LETTERHEAD] July 3, 2024 Division of Corporation Finance Office of Mergers & Acquisitions United States Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549-3561 Re: Assure Holdings Corp. Schedule TO-I filed June 21, 2024 File No. 005-92920 Ladies and Gentlemen: Set forth below are the responses of Assure Holdings Corp. (the “Company,” “we,” “us” or “ |
|
| July 3, 2024 |
Amended Letter of Transmittal dated July 3, 2024 Exhibit a(1)(iii) LETTER OF TRANSMITTAL Regarding Convertible Note Exchange Offer Issued By ASSURE HOLDINGS CORP. |
|
| July 3, 2024 |
Amendment No. 1 to Offer Letter dated July 3, 2024 Exhibit (a)(1)(ii) AMENDMENT NO. 1 ASSURE HOLDINGS CORP. OFFER TO EXCHANGE SHARES OF COMMON STOCK FOR OUTSTANDING 9% CONVERTIBLE NOTES DUE 2023 AND 2024 ISSUED BY ASSURE HOLDINGS CORP. JULY 3, 2024 THE CONVERTIBLE NOTE EXCHANGE OFFER WILL EXPIRE AT 11:59 P.M., DENVER TIME, ON JULY 19, 2024 UNLESS EXTENDED (SUCH TIME AND DATE, AS IT MAY BE EXTENDED, THE “EXPIRATION DATE”). This Amendment No. 1 (thi |
|
| June 26, 2024 |
June 26, 2024 Via EDGAR Transmission United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N. |
|
| June 26, 2024 |
June 26, 2024 Via EDGAR Transmission United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N. |
|
| June 25, 2024 |
SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| June 24, 2024 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ASSURE HOLDINGS CORP. (Exact name of registrant as specified in its charter) Nevada 809913 82-2726719 (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identi |
|
| June 24, 2024 |
Calculation for Filing Fee Table Exhibit 107 Calculation of Filing Fee Tables S-1 (Form Type) ASSURE HOLDINGS CORP. |
|
| June 21, 2024 |
Form of Cover Letter to Holders Exhibit (a)(1)(v) June 21, 2024 [ADDRESS] [EMAIL ADDRESS] Re: Tender Offer to Exchange Convertible Notes for Shares of Common Stock Dear Holder: We are writing to inform you of important information relating to a tender offer by Assure Holdings Corp. |
|
| June 21, 2024 |
Exhibit a(1)(ii) LETTER OF TRANSMITTAL Regarding Convertible Note Exchange Offer Issued By ASSURE HOLDINGS CORP. |
|
| June 21, 2024 |
Offer Letter dated June 21, 2024 Exhibit (a)(1)(i) ASSURE HOLDINGS CORP. OFFER TO EXCHANGE SHARES OF COMMON STOCK FOR OUTSTANDING 9% CONVERTIBLE NOTES DUE 2023 AND 2024 ISSUED BY ASSURE HOLDINGS CORP. THE CONVERTIBLE NOTE EXCHANGE OFFER WILL EXPIRE AT 11:59 P.M., DENVER TIME, ON JULY 19, 2024 UNLESS EXTENDED (SUCH TIME AND DATE, AS IT MAY BE EXTENDED, THE “EXPIRATION DATE”). The Offer For a limited period of time, Assure Holdings |
|
| June 21, 2024 |
Form of Confirmation email/letter to Holders who Elect to Participate in the Offer Exhibit (a)(1)(iv) Form of Letter from the Company to Convertible Debenture Holders in Connection with the Exchange to the Convertible Debentures John Farlinger 7887 East Belleview Avenue, Suite 240 Denver, Colorado 80111 [DATE] [SHAREHOLDER NAME/ADDRESS] Dear Shareholder: This letter serves to inform you that Assure Holdings Corp. |
|
| June 21, 2024 |
EX 107-FILING FEES Calculation of Filing Fees Table SC TO-I (Form Type) ASSURE HOLDINGS CORP. |
|
| June 21, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO Tender Offer Statement Under Section 13(e)(1) of the Securities Exchange Act of 1934 ASSURE HOLDINGS CORP. (Name of Subject Company (Issuer) and Filing Person (Offeror)) 9% CONVERTIBLE DEBENTURES DUE 2023 AND 2024 (Title of Class of Securities) 04625J303 (CUSIP Number of Common Stock Underlying Debentures) John Far |
|
| June 21, 2024 |
Exhibit (a)(1)(iii) NOTICE OF WITHDRAWAL OF TENDER REGARDING CONVERTIBLE DEBENTURES OF ASSURE HOLDINGS CORP. |
|
| June 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 11, 2024 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission File |
|
| June 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 11, 2024 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission File |
|
| June 7, 2024 |
Exhibit 10.2 SETTLEMENT AGREEMENT This Settlement Agreement (the “Agreement”) is entered into among the United States of America, acting through the United States Department of Justice and on behalf of the Office of Inspector General (OIG-HHS) of the Department of Health and Human Services (HHS) (collectively, the “United States”), the State of Colorado, Assure Holdings Corp. and Assure Neuromonit |
|
| June 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-40785 AS |
|
| June 7, 2024 |
Exhibit 3.1 Certified Copy 6/4/2024 10:59:32 AM Work Order Number: W2024060400370 Reference Number: 20244104702 Through Date: 6/4/2024 10:59:32 AM Corporate Name: ASSURE HOLDINGS CORP The undersigned filing officer hereby certifies that the attached copies are true and exact copies of all requested statements and related subsequent documentation filed with the Secretary of State’s Office, Commerci |
|
| June 7, 2024 |
Exhibit 10.1 Payment Accommodation Agreement December 29th, 2023 Centurion Financial Trust (the “Lender”) has agreed to provide a payment accommodation to Assure Holdings Corporation (the “Borrower”) pursuant to that certain commitment letter issued by the Lender in favour of the Borrower on March 8, 2021, and accepted by the Borrower on the same date (the “Original Commitment Letter” and, as amen |
|
| May 28, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 21, 2024 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission File N |
|
| May 28, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 21, 2024 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission File N |
|
| May 22, 2024 |
Exhibit 99.1 INVESTOR PRESENTATION May 22, 2024 I Nasdaq: IONM COMPANY OVERVIEW HISTORIC ASSURE BUSINESS MODEL Assure Holdings is a healthcare services company providing best-in-class, outsourced Intraoperative NeurophysiologicalMonitoring (“IONM”) ASSURE OPERATIONS Providing technical and professional medical services IONM MEDICAL SERVICES A group of procedures used during surgery that assists su |
|
| May 22, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 22, 2024 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission File N |
|
| May 22, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 22, 2024 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission File N |
|
| May 22, 2024 |
Exhibit 99.1 INVESTOR PRESENTATION May 22, 2024 I Nasdaq: IONM COMPANY OVERVIEW HISTORIC ASSURE BUSINESS MODEL Assure Holdings is a healthcare services company providing best-in-class, outsourced Intraoperative NeurophysiologicalMonitoring (“IONM”) ASSURE OPERATIONS Providing technical and professional medical services IONM MEDICAL SERVICES A group of procedures used during surgery that assists su |
|
| May 21, 2024 |
Exhibit 99.1 May 16, 2024 Assure Announces it will Remain Listed on the Nasdaq Capital Market Pursuant to Nasdaq Panel Decision DENVER, May 16, 2024 (GLOBE NEWSWIRE) - Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, announced today it received a written notice from the Nasdaq Listing Qualificatio |
|
| May 21, 2024 |
Certificate of Amendment dated May 17, 2024 Exhibit 3.1 Filed in the Office of Secretary of State State Of Nevada Business Number E0232292017-6 Filing Number 20244068110 Filed On 5/17/2024 2:32:00 PM Number of Pages 2 |
|
| May 21, 2024 |
Assure & Danam Reschedule Corporate Update Call & Webcast Exhibit 99.2 Assure & Danam Reschedule Corporate Update Call & Webcast DENVER, May 17, 2024 (GLOBE NEWSWIRE) - Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, announced today that management has rescheduled the joint corporate update call with Danam for Wednesday, May 22, 2024 at 4:00 PM Eastern |
|
| May 21, 2024 |
Exhibit 99.1 May 16, 2024 Assure Announces it will Remain Listed on the Nasdaq Capital Market Pursuant to Nasdaq Panel Decision DENVER, May 16, 2024 (GLOBE NEWSWIRE) - Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, announced today it received a written notice from the Nasdaq Listing Qualificatio |
|
| May 21, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 16, 2024 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission File N |
|
| May 21, 2024 |
Assure & Danam Reschedule Corporate Update Call & Webcast Exhibit 99.2 Assure & Danam Reschedule Corporate Update Call & Webcast DENVER, May 17, 2024 (GLOBE NEWSWIRE) - Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, announced today that management has rescheduled the joint corporate update call with Danam for Wednesday, May 22, 2024 at 4:00 PM Eastern |
|
| May 21, 2024 |
Certificate of Amendment dated May 17, 2024 Exhibit 3.1 Filed in the Office of Secretary of State State Of Nevada Business Number E0232292017-6 Filing Number 20244068110 Filed On 5/17/2024 2:32:00 PM Number of Pages 2 |
|
| May 21, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 16, 2024 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission File N |
|
| May 16, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One) ¨ Form 10-K ¨ Form 20-F ¨ Form 11-K x Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For Period Ended: March 31, 2024 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Report on Form 10-Q ¨ Transition Report on Fo |
|
| May 16, 2024 |
Exhibit 99.1 May 16, 2024 Assure Announces Approval of Increase in Authorized Capital at Adjourned Special Shareholders Meeting DENVER, May 16, 2024 (GLOBE NEWSWIRE) - Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, announced today that at its adjourned Special Shareholder Meeting held on May 14, |
|
| May 16, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 14, 2024 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission File N |
|
| May 16, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 14, 2024 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission File N |
|
| May 16, 2024 |
Exhibit 99.1 May 16, 2024 Assure Announces Approval of Increase in Authorized Capital at Adjourned Special Shareholders Meeting DENVER, May 16, 2024 (GLOBE NEWSWIRE) - Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, announced today that at its adjourned Special Shareholder Meeting held on May 14, |
|
| May 8, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 6, 2024 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| May 8, 2024 |
Exhibit 99.1 May 6, 2024 Assure Reminds Stockholders To Vote For The Proposed Increase in Authorized Shares - Of the Votes Received to Date, More than 95% Are Voting in Favor of the Increase - More Votes Are Needed to Reach 50% of the Outstanding Shares Required for the Increase - Every Vote Is Important to Avoid Delay in Completion of the Increase DENVER, May 6, 2024 (GLOBE NEWSWIRE) - Assure Hol |
|
| May 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 6, 2024 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| May 8, 2024 |
Exhibit 99.1 May 6, 2024 Assure Reminds Stockholders To Vote For The Proposed Increase in Authorized Shares - Of the Votes Received to Date, More than 95% Are Voting in Favor of the Increase - More Votes Are Needed to Reach 50% of the Outstanding Shares Required for the Increase - Every Vote Is Important to Avoid Delay in Completion of the Increase DENVER, May 6, 2024 (GLOBE NEWSWIRE) - Assure Hol |
|
| May 8, 2024 |
SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| May 3, 2024 |
Executive Compensation Agreement between Tim Canning and Danam Health Inc. Exhibit 10.24 DANAM HEALTH, INC. EXECUTIVE EMPLOYMENT AGREEMENT THIS EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) is entered into this January 18th 2024, to be effective as of the Effective Date as defined below between Danam Health, Inc., a Delaware corporation (the “Company”), and Timothy Canning, an individual (the “Executive”) (each of the Company and Executive are referred to herein as a |
|
| May 3, 2024 |
Consent of Suren Ajjarapu to be Named as a Director Nominee. Exhibit 99.3 CONSENT TO BE NAMED AS A DIRECTOR NOMINEE Pursuant to Rule 438 promulgated under the Securities Act of 1933, as amended (the “Securities Act”), the undersigned hereby consents to being named as a director nominee to the board of directors of Danam Health Holding Corporation and to the disclosure of the undersigned’s biographical information included in the Registration Statement on Fo |
|
| May 3, 2024 |
Consent of Donald W. Anderson to be Named as a Director Nominee. Exhibit 99.6 CONSENT TO BE NAMED AS A DIRECTOR NOMINEE Pursuant to Rule 438 promulgated under the Securities Act of 1933, as amended (the “Securities Act”), the undersigned hereby consents to being named as a director nominee to the board of directors of Danam Health Holding Corporation and to the disclosure of the undersigned’s biographical information included in the Registration Statement on Fo |
|
| May 3, 2024 |
Consent of Sajid Syed to be Named as a Director Nominee. Exhibit 99.5 CONSENT TO BE NAMED AS A DIRECTOR NOMINEE Pursuant to Rule 438 promulgated under the Securities Act of 1933, as amended (the “Securities Act”), the undersigned hereby consents to being named as a director nominee to the board of directors of Danam Health Holding Corporation and to the disclosure of the undersigned’s biographical information included in the Registration Statement on Fo |
|
| May 3, 2024 |
Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): April 30, 2024 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission File |
|
| May 3, 2024 |
Consent of Prashant Patel to be Named as a Director Nominee. Exhibit 99.4 CONSENT TO BE NAMED AS A DIRECTOR NOMINEE Pursuant to Rule 438 promulgated under the Securities Act of 1933, as amended (the “Securities Act”), the undersigned hereby consents to being named as a director nominee to the board of directors of Danam Health Holding Corporation and to the disclosure of the undersigned’s biographical information included in the Registration Statement on Fo |
|
| May 3, 2024 |
Lease between GVI-IP Tampe Office Owner and Wellgistics Exhibit 10.23 LEASE GVI-IP TAMPA OFFICE OWNER, LLC, a Delaware limited liability company as Landlord AND WELLGISTICS, LLC, a Florida limited liability company, and DANAM HEALTH, INC., a Delaware corporation as Tenant March 23 , 2024 * * * * * * The mailing, delivery or negotiation of this Lease by Landlord or its agent or attorney shall not be deemed an offer by Landlord to enter into this Lease o |
|
| May 3, 2024 |
Exhibit 10.25 MEMBERSHIP INTEREST PURCHASE AGREEMENT This MEMBERSHIP INTEREST PURCHASE AGREEMENT (“Agreement”) is made as of January 2023, by and among Nikul Panchal, an individual resident of the State of Florida (“Seller”) and DANAM HEALTH, Inc., a Delaware corporation (“Buyer”). Buyer, Company and Seller are each referred to herein as a “Party” and collectively as “Parties.” RECITALS Seller own |
|
| May 3, 2024 |
Exhibit 10.28 THIRD AMENDMENT TO MEMBERSHIP INTEREST PURCHASE AGREEMENT THIS THIRD AMENDMENT TO MEMBERSHIP INTEREST PURCHASE AGREEMENT (this “Third Amendment”) is effective as of this 22nd day of March, 2024, by and among (i) DANAM HEALTH, INC., a Delaware corporation (“Buyer”); (ii) WELLGISTICS, LLC, a Florida limited liability company (the “Company”) (iii) STRATEGIX GLOBAL LLC, a Utah limited li |
|
| May 3, 2024 |
As filed with the Securities and Exchange Commission on May 2, 2024 Table of Contents As filed with the Securities and Exchange Commission on May 2, 2024 Registration Statement No. |
|
| May 3, 2024 |
Exhibit 10.27 Execution Copy MEMBERSHIP INTEREST PURCHASE AGREEMENT by and among DANAM HEALTH, INC., WELLGISTICS, LLC STRATEGIX GLOBAL LLC, NOMAD CAPITAL LLC, JOUSKA HOLDINGS LLC, The Seller Owners and BRIAN NORTON, as Seller Representative May 11, 2023 TABLE OF CONTENTS Page ARTICLE I PURCHASE AND SALE OF THE INTERESTS 1 1.1 Purchase of Interests 1 1.2 Closing Cash Payment 2 1.3 Closing Payment A |
|
| May 3, 2024 |
Exhibit 10.26 AMENDMENT THIS “AMEDMENT” is made effective as of 1 April 2023 to that certain Membership Interest Purchase Agreement dated January 2023 (the “Agreement”) by and between Nikul Panchal (“Seller”) on the one hand and Danam Health, Inc. (“Buyer”) on the other hand. Capitalized terms not otherwise defined shall have the same meaning ascribed to them herein as in the Agreement. The Agreem |
|
| May 3, 2024 |
Exhibit 10.21 VOTING AND SUPPORT AGREEMENT THIS AGREEMENT (this “Agreement”) is made as of the day of , 2024. BETWEEN: THE PERSONS LISTED ON APPENDIX A HERETO, (collectively, the “Stockholders” and each individually a “Stockholder”) - and - DANAM HEALTH, INC., a Delaware corporation (“Danam”) WHEREAS, each Stockholder is the registered and/or direct or indirect beneficial owner of the shares of co |
|
| May 3, 2024 |
Calculation of Filing Fee Table. Exhibit 107 Calculation of Filing Fee Tables Form S-4 ASSURE HOLDINGS CORP. Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Proposed Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Newly Registered Securities Fees Previously Paid Equity Common stock, par val |
|
| May 3, 2024 |
Exhibit 99.2 CONSENT OF THE MENTOR GROUP, INC. The Board of Directors Assure Holdings Corp. 7887 East Belleview Avenue, Suite 240 Denver, Colorado 80111 Dear Board of Directors: We hereby consent to the inclusion of our opinion letter, dated February 12, 2024, to the Board of Directors of Assure Holdings Corp. in the proxy statement/prospectus included in the Registration Statement filed with the |
|
| April 26, 2024 |
Exhibit 10.4 ASSURE HOLDINGS CORP. EQUITY INCENTIVE PLAN APPROVED BY THE SHAREHOLDERS AND ADOPTED BY THE BOARD OF DIRECTORS ON DECEMBER 10, 2020 AS AMENDED BY THE BOARD ON NOVEMBER 4, 2021 AND APPROVED BY SHAREHOLDERS ON DECEMBER 9, 2021 ASSURE HOLDINGS CORP. EQUITY INCENTIVE PLAN Section 1 - Purpose; Eligibility 1.1 General Purpose. The name of this plan is the Assure Holdings Corp. Equity Incent |
|
| April 26, 2024 |
SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy Statement x Definitive Additional Materials ¨ Soliciting Material Pursuant to § 240. |
|
| April 26, 2024 |
Exhibit 10.3 ASSURE HOLDINGS CORP. STOCK OPTION PLAN APPROVED BY THE SHAREHOLDERS AND ADOPTED BY THE BOARD OF DIRECTORS ON DECEMBER 10, 2020 AS AMENDED BY THE BOARD OF DIRECTORS ON NOVEMBER 4, 2021, AND APPROVED BY THE SHAREHOLDERS ON DECEMBER 9, 2021 B-1 PART 1 INTERPRETATION 1.1 Defined Terms. For the purposes of this Plan, the following terms shall have the following meanings: “Administrator” h |
|
| April 26, 2024 |
Assure Holdings Corp. Incentive Compensation Recovery Plan Exhibti 97 Assure Holdings Corp. INCENTIVE COMPENSATION Recovery POLICY 1.Introduction. The Board of Directors (the “Board”) of Assure Holdings Corp. (the “Company”) believes that it is in the best interests of the Company and its shareholders to create and maintain a culture that emphasizes integrity and accountability and that reinforces the Company's compensation philosophy. The Board has there |
|
| April 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-40785 ASSURE |
|
| April 26, 2024 |
DESCRIPTION OF SECURITIES Authorized Capital Stock Our authorized capital stock consists of 9,000,000 shares of common stock, par value $0. |
|
| April 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 24, 2024 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission File |
|
| April 26, 2024 |
SUBSIDIARIES SUBSIDIARIES Legal Name Jurisdiction Ownership Assure Holdings Corp. - Subsidiaries Assure Holdings, Inc. Colorado 100% Assure Holdings, Inc. - Subsidiaries Assure Neuromonitoring LLC Colorado 100% Assure Networks, LLC Colorado 100% Assure Equipment Leasing, LLC Colorado 100% Velocity Revenue Cycle, LLC Colorado 100% Assure Telehealth Providers, LLC Colorado 100% Assure Neuromonitorin |
|
| April 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 24, 2024 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission File |
|
| April 24, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 18, 2024 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission File |
|
| April 24, 2024 |
SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| April 24, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 18, 2024 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission File |
|
| April 16, 2024 |
SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| April 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 8, 2024 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission File |
|
| April 12, 2024 |
EXHIBIT 10.1 EXCHANGE AGREEMENT EXCHANGE AGREEMENT (the “Agreement”) is made as of the April 8, 2024, by and between, Assure Holdings Corp., a Nevada corporation (the “Company”), and the Holder signatory hereto (the “Holder”). WHEREAS, prior to the date hereof, pursuant to that certain Debenture Agreement, dated as of June 9, 2021, by and between the Company and the investors party thereto (as ame |
|
| April 12, 2024 |
Exhibit 4.1 Convertible Note THIS NOTE AND THE SECURITIES ISSUABLE UPON THE CONVERSION HEREOF HAVE NOT BEEN AND WILL NOT BE REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR UNDER THE APPLICABLE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES. THESE SECURITIES MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED, DIRECTLY OR INDIRECTLY, EXCEPT AS PERMI |
|
| April 12, 2024 |
Exhibit 2.1 PARTIAL WAIVER AND AMENDMENT AGREEMENT This Partial Waiver Agreement (the “Waiver”) by and between Assure Holdings Corp. (“Assure”), Assure Acquisition Corp. (“Merger Sub”) and Danam Health, Inc. (“Danam”) is dated and effective as of this 8th day of April 2024. Each of Assure, Merger Sub and Danam are a “Party,” and collectively, the “Parties.” RECITALS WHEREAS, Assure, Merger Sub and |
|
| April 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 8, 2024 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission File |
|
| April 12, 2024 |
Subscription Agreement with Innovation dated April 8, 2024 Exhibit 10.2 SUBSCRIPTION AGREEMENT ASSURE HOLDINGS CORP. This SUBSCRIPTION AGREEMENT (this “Agreement”), dated as of April 8, 2024 is made by and between Assure Holdings Corp., a Nevada corporation (the “Company”), and Innovation Neuormonitoring LLC (the “Subscriber”). WHEREAS, the Company and the Subscriber have previously entered into an Asset Purchase Agreement dated August 2, 2023 (the “APA”) |
|
| April 12, 2024 |
Exhibit 3.1 Amended and Restated By-Laws A by-law relating generally to the conduct of the affairs of ASSURE HOLDINGS CORP. BE IT ENACTED as a by-law of Assure Holdings Corp. (the “Corporation”) as follows: 1 - DEFINITIONS 1.1 Definitions 1.1.1 In this By-law and all other by-laws of the Corporation, unless the context otherwise specifies or requires: “Act” means Nevada’s general corporate law set |
|
| April 12, 2024 |
Convertible Note issued to Danam Health Inc. dated April 8, 2024 Exhibit 4.1 Convertible Note THIS NOTE AND THE SECURITIES ISSUABLE UPON THE CONVERSION HEREOF HAVE NOT BEEN AND WILL NOT BE REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR UNDER THE APPLICABLE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES. THESE SECURITIES MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED, DIRECTLY OR INDIRECTLY, EXCEPT AS PERMI |
|
| April 12, 2024 |
Exchange Agreement with Centurion dated April 8, 2024 EXHIBIT 10.1 EXCHANGE AGREEMENT EXCHANGE AGREEMENT (the “Agreement”) is made as of the April 8, 2024, by and between, Assure Holdings Corp., a Nevada corporation (the “Company”), and the Holder signatory hereto (the “Holder”). WHEREAS, prior to the date hereof, pursuant to that certain Debenture Agreement, dated as of June 9, 2021, by and between the Company and the investors party thereto (as ame |
|
| April 12, 2024 |
Exhibit 3.1 Amended and Restated By-Laws A by-law relating generally to the conduct of the affairs of ASSURE HOLDINGS CORP. BE IT ENACTED as a by-law of Assure Holdings Corp. (the “Corporation”) as follows: 1 - DEFINITIONS 1.1 Definitions 1.1.1 In this By-law and all other by-laws of the Corporation, unless the context otherwise specifies or requires: “Act” means Nevada’s general corporate law set |
|
| April 12, 2024 |
Exhibit 10.2 SUBSCRIPTION AGREEMENT ASSURE HOLDINGS CORP. This SUBSCRIPTION AGREEMENT (this “Agreement”), dated as of April 8, 2024 is made by and between Assure Holdings Corp., a Nevada corporation (the “Company”), and Innovation Neuormonitoring LLC (the “Subscriber”). WHEREAS, the Company and the Subscriber have previously entered into an Asset Purchase Agreement dated August 2, 2023 (the “APA”) |
|
| April 12, 2024 |
Partial Waiver and Amendment Agreement dated April 8, 2024 Exhibit 2.1 PARTIAL WAIVER AND AMENDMENT AGREEMENT This Partial Waiver Agreement (the “Waiver”) by and between Assure Holdings Corp. (“Assure”), Assure Acquisition Corp. (“Merger Sub”) and Danam Health, Inc. (“Danam”) is dated and effective as of this 8th day of April 2024. Each of Assure, Merger Sub and Danam are a “Party,” and collectively, the “Parties.” RECITALS WHEREAS, Assure, Merger Sub and |
|
| April 2, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Form 10-D ☐ Form N-SAR ☐ Form N-CSR (Check One) ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: December 31, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report |
|
| April 1, 2024 |
Amendment Number One to Asset Purchase Agreement dated March 26, 2024 Exhibit 10.1 Execution Version FIRST AMENDMENT TO ASSET PURCHASE AGREEMENT THIS FIRST AMENDMENT TO ASSET PURCHASE AGREEMENT (this “Amendment”) is made and entered into as of March 26, 2024, by and among National Neuromonitoring Services, LLC, a Texas limited liability company (“Purchaser”), Assure Neuromonitoring, LLC, a Colorado limited liability company (“Assure Neuromonitoring”) Assure Networks |
|
| April 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 26, 2024 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission File |
|
| April 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 26, 2024 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission File |
|
| April 1, 2024 |
ASSURE HOLDINGS CORP. Unaudited Pro Forma Condensed Consolidated Financial Information Exhibit 99.1 ASSURE HOLDINGS CORP. Unaudited Pro Forma Condensed Consolidated Financial Information On March 26, 2024, Assure Holdings Corp. (the “Company”) completed the sale of certain assets held by its direct and indirect wholly owned subsidiaries, Assure Neuromonitoring, LLC, Assure Networks, LLC, Assure Networks Texas Holdings, LLC and Assure Networks Texas Holdings II, LLC (collectively, th |
|
| April 1, 2024 |
Non-Competition Agreement dated March 26, 2024 Exhibit 10.3 Execution Version NONCOMPETITION AGREEMENT THIS NONCOMPETITION AGREEMENT (this “Agreement”) is made and entered into as of March 26, 2024 (the “Effective Date”), by and among Assure Neuromonitoring, LLC, a Colorado limited liability (“Assure Neuromonitoring”), Assure Networks, LLC, a Colorado limited liability company (“Assure Networks”), Assure Networks Texas Holdings, LLC, a Texas l |
|
| April 1, 2024 |
Exhibit 10.1 Execution Version FIRST AMENDMENT TO ASSET PURCHASE AGREEMENT THIS FIRST AMENDMENT TO ASSET PURCHASE AGREEMENT (this “Amendment”) is made and entered into as of March 26, 2024, by and among National Neuromonitoring Services, LLC, a Texas limited liability company (“Purchaser”), Assure Neuromonitoring, LLC, a Colorado limited liability company (“Assure Neuromonitoring”) Assure Networks |
|
| April 1, 2024 |
ASSURE HOLDINGS CORP. Unaudited Pro Forma Condensed Consolidated Financial Information Exhibit 99.1 ASSURE HOLDINGS CORP. Unaudited Pro Forma Condensed Consolidated Financial Information On March 26, 2024, Assure Holdings Corp. (the “Company”) completed the sale of certain assets held by its direct and indirect wholly owned subsidiaries, Assure Neuromonitoring, LLC, Assure Networks, LLC, Assure Networks Texas Holdings, LLC and Assure Networks Texas Holdings II, LLC (collectively, th |
|
| April 1, 2024 |
Nominee Agreement dated March 26, 2024 Exhibit 10.2 Execution Version NOMINEE AGREEMENT This Nominee Agreement (this “Agreement”) is made and entered into as of March 26, 2024 (the “Effective Date”), by and between Assure Neuromonitoring, LLC, a Colorado limited liability company (“Assure Neuromonitoring”), Assure Telehealth Providers, LLC, a Colorado limited liability company (“Assure Telehealth” and together with Assure Neuromonitori |
|
| April 1, 2024 |
Exhibit 10.3 Execution Version NONCOMPETITION AGREEMENT THIS NONCOMPETITION AGREEMENT (this “Agreement”) is made and entered into as of March 26, 2024 (the “Effective Date”), by and among Assure Neuromonitoring, LLC, a Colorado limited liability (“Assure Neuromonitoring”), Assure Networks, LLC, a Colorado limited liability company (“Assure Networks”), Assure Networks Texas Holdings, LLC, a Texas l |
|
| April 1, 2024 |
Exhibit 10.2 Execution Version NOMINEE AGREEMENT This Nominee Agreement (this “Agreement”) is made and entered into as of March 26, 2024 (the “Effective Date”), by and between Assure Neuromonitoring, LLC, a Colorado limited liability company (“Assure Neuromonitoring”), Assure Telehealth Providers, LLC, a Colorado limited liability company (“Assure Telehealth” and together with Assure Neuromonitori |
|
| March 29, 2024 |
SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| March 19, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 13, 2024 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission File |
|
| March 19, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 13, 2024 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission File |
|
| March 19, 2024 |
Exhibit 10.1 EXCHANGE AGREEMENT EXCHANGE AGREEMENT (the “Agreement”) is made as of the March 13, 2024, by and between, Assure Holdings Corp., a Nevada corporation (the “Company”), and the Holder signatory hereto (the “Holder”). WHEREAS, prior to the date hereof, pursuant to that certain Subscription Agreement, dated as of May 11, 2020, by and between the Company and the investors party thereto (as |
|
| March 19, 2024 |
Form of Exchange Agreement dated March 13, 2024 Exhibit 10.1 EXCHANGE AGREEMENT EXCHANGE AGREEMENT (the “Agreement”) is made as of the March 13, 2024, by and between, Assure Holdings Corp., a Nevada corporation (the “Company”), and the Holder signatory hereto (the “Holder”). WHEREAS, prior to the date hereof, pursuant to that certain Subscription Agreement, dated as of May 11, 2020, by and between the Company and the investors party thereto (as |
|
| March 15, 2024 |
Asset Purchase Agreement dated March 11, 2024 Exhibit 10.1 PORTIONS OF THIS EXHIBIT (INDICATED WITH [***]) HAVE BEEN OMITTED PURSUANT TO ITEM 601(B)(10)(IV) AS THE REGISTRANT HAS DETERMINED THAT (I) THE OMITTED INFORMATION IS NOT MATERIAL AND (II) THE OMITTED INFORMATION IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. Execution Version ASSET PURCHASE AGREEMENT by and among National Neuromonitoring Services, LLC, (Purchaser) |
|
| March 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 11, 2024 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission File |
|
| March 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 11, 2024 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission File |
|
| March 15, 2024 |
Exhibit 10.1 PORTIONS OF THIS EXHIBIT (INDICATED WITH [***]) HAVE BEEN OMITTED PURSUANT TO ITEM 601(B)(10)(IV) AS THE REGISTRANT HAS DETERMINED THAT (I) THE OMITTED INFORMATION IS NOT MATERIAL AND (II) THE OMITTED INFORMATION IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. Execution Version ASSET PURCHASE AGREEMENT by and among National Neuromonitoring Services, LLC, (Purchaser) |
|
| March 12, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 11, 2024 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission File |
|
| March 12, 2024 |
Exhibit 99.1 March 11, 2024 Assure Holdings Enters into Agreement to Sell Certain of its Assets to MPOWER Health DENVER, March 11, 2024 (GLOBE NEWSWIRE) - Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, today announced that it has entered into an agreement to sell certain assets of its IONM busin |
|
| March 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 11, 2024 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission File |
|
| March 12, 2024 |
Exhibit 99.1 March 11, 2024 Assure Holdings Enters into Agreement to Sell Certain of its Assets to MPOWER Health DENVER, March 11, 2024 (GLOBE NEWSWIRE) - Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, today announced that it has entered into an agreement to sell certain assets of its IONM busin |
|
| February 15, 2024 |
Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 9, 2024 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission Fi |
|
| February 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 9, 2024 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission Fi |
|
| February 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 7, 2024 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission Fi |
|
| February 13, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 7, 2024 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission Fi |
|
| February 12, 2024 |
Assure Holdings Corp. Announces Business Combination with Danam Health, Inc. Exhibit 99.1 Assure Holdings Corp. Announces Business Combination with Danam Health, Inc. Danam Health, Inc., a private pharmaceutical and healthcare services company, to merge with Assure Holdings Corp. in an all-stock transaction DENVER, February 12, 2024 /Globe Newswire/ - Assure Holdings Corp. (“Assure”) (Nasdaq: IONM) today announced that it has entered into a definitive Agreement and Plan of |
|
| February 12, 2024 |
Assure Holdings Corp. Announces Business Combination with Danam Health, Inc. Exhibit 99.1 Assure Holdings Corp. Announces Business Combination with Danam Health, Inc. Danam Health, Inc., a private pharmaceutical and healthcare services company, to merge with Assure Holdings Corp. in an all-stock transaction DENVER, February 12, 2024 /Globe Newswire/ - Assure Holdings Corp. (“Assure”) (Nasdaq: IONM) today announced that it has entered into a definitive Agreement and Plan of |
|
| February 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 12, 2024 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission F |
|
| February 12, 2024 |
Exhibit 2.1 EXECUTION VERSION AGREEMENT AND PLAN OF MERGER BY AND AMONG Assure holdings corp., ASSURE ACQUISITION CORP. AND DANAM HEALTH, INC. DATED AS OF FEBRUARY 12, 2024 TABLE OF CONTENTS Page Article 1 CERTAIN DEFINITIONS 1 Section 1.1 Definitions 1 Section 1.2 Certain Defined Terms 14 Article 2 MERGER; CLOSING 15 Section 2.1 Merger 15 Section 2.2 Effects of the Merger 15 Section 2.3 Closing; |
|
| February 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 12, 2024 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission F |
|
| February 12, 2024 |
Exhibit 2.1 EXECUTION VERSION AGREEMENT AND PLAN OF MERGER BY AND AMONG Assure holdings corp., ASSURE ACQUISITION CORP. AND DANAM HEALTH, INC. DATED AS OF FEBRUARY 12, 2024 TABLE OF CONTENTS Page Article 1 CERTAIN DEFINITIONS 1 Section 1.1 Definitions 1 Section 1.2 Certain Defined Terms 14 Article 2 MERGER; CLOSING 15 Section 2.1 Merger 15 Section 2.2 Effects of the Merger 15 Section 2.3 Closing; |
|
| February 12, 2024 |
Filed by Assure Holdings Corp. Filed by Assure Holdings Corp. (Commission File No.: 001-40785) Pursuant to Rule 425 of the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: Assure Holdings Corp. (Commission File No.: 001-40785) The following communication was sent to Assure Holdings Corp. employees via electronic mail on February 12, 2024 Team, I am excited t |
|
| February 9, 2024 |
ARHH / Assure Holdings Corp / MANCHESTER MANAGEMENT CO LLC Passive Investment SC 13G/A 1 d1097359813g-a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* Assure Holdings Corp. (Name of Issuer) Common Stock, $0.001 par value per share (Title of Class of Securities) 04625J303 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the approp |
|
| January 30, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): January 24, 2024 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission Fi |
|
| January 25, 2024 |
Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): January 19, 2024 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission Fi |
|
| January 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 8, 2024 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission Fil |
|
| January 3, 2024 |
EXHIBIT 10.1 EMPLOYMENT AGREEMENT This Employment Agreement (the “Agreement”) is made and entered into as of December 27, 2023, by and between John Farlinger (“Employee”) and Assure Holdings Corp., a Nevada corporation (the “Company” or “Employer”). RECITALS A. The Company wishes to memorialize the terms and conditions of Employee’s employment as previously agreed to between the Company |
|
| January 3, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 27, 2023 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission F |
|
| January 3, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): December 27, 2023 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission F |
|
| December 22, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-4078 |
|
| December 5, 2023 |
SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| November 24, 2023 |
SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| November 24, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): November 17, 2023 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission F |
|
| November 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Form 10-D ☐ Form N-SAR ☐ Form N-CSR (Check One) ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: September 30, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Repor |
|
| November 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 3, 2023 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission Fi |
|
| November 8, 2023 |
Offer Letter between Assure Holdings Corp. and Paul Webster dated November 3, 2023 Exhibit 10.1 November 3, 2023 Paul Webster 1460 Conifer Trail Elizabeth, CO 80107 RE: Letter of Transfer – Interim CFO Dear Paul: It is with great pleasure that I present to you this confidential written offer to transfer to the role of Interim CFO with Assure Neuromonitoring (Assure). In this assignment, you will report directly to John Farlinger and will be a key contributor in our Finance Depar |
|
| September 22, 2023 |
As filed with the Securities and Exchange Commission on September 22, 2023 Table of Contents As filed with the Securities and Exchange Commission on September 22, 2023 Registration No. |
|
| September 22, 2023 |
Letter from Baker Tilly US, LLP Exhibit 16.1 September 22, 2023 Securities and Exchange Commission 100 F Street, NE Washington, DC 20549 Dear Ladies and Gentlemen: We are independent registered public accounting firm for Assure Holdings Corp. (the “Company”). We have read the Company’s disclosure set forth under the heading “Changes in Certifying Accountants” in the Company’s registration statement on Form S-1 dated September 22 |
|
| September 22, 2023 |
Calculation of Filing Fee Table Exhibit 107 Calculation of Filing Fee Table Form S-1 (Form Type) ASSURE HOLDINGS CORP. |
|
| September 20, 2023 |
Investor Presentation September 2023 | NASDAQ: IONM Exhibit 99.1 Investor Presentation September 2023 | NASDAQ: IONM Cautionary Note regarding Forward - Looking Statements This presentation may contain “forward - looking statements” within the meaning of applicable securities laws. Forward - looking sta tements may generally be identified by the use of the words "anticipates," "expects," "intends," "plans," "should," "could," "wo uld," "may," "will |
|
| September 20, 2023 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): September 20, 2023 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission |
|
| September 19, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): September 19, 2023 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission |
|
| September 19, 2023 |
Assure Holdings Corp. Announces Exploration of Strategic Alternatives Exhibit 99.1 Assure Holdings Corp. Announces Exploration of Strategic Alternatives DENVER, September 19, 2023 (GLOBE NEWSWIRE) - Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, today announced that its Board of Directors has initiated a process to explore strategic alternatives. In consultation w |
|
| September 5, 2023 |
Auditor Letter, dated August 29, 2023 Exhibit 16.1 August 29, 2023 Securities and Exchange Commission 100 F Street, NE Washington, DC 20549 Dear Ladies and Gentlemen: We are the independent registered public accounting firm for Assure Holdings Corp. (the “Company”). We have read the Company’s disclosure set forth in Item 4.01 “Changes in Registrant’s Certifying Accountant” of the Company’s Current Report on Form 8-K dated August 29, 2 |
|
| September 5, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 29, 2023 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission Fil |
|
| September 5, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): August 29, 2023 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission Fil |
|
| August 22, 2023 |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 16, 2023 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission Fil |
|
| August 15, 2023 |
Assure Holdings Reports Second Quarter 2023 Financial Results Exhibit 99.1 7887 E. Belleview Ave. Suite 500 Denver, CO 80111 (720)287-3093 Assure Holdings Reports Second Quarter 2023 Financial Results DENVER, August 15, 2023 (GLOBE NEWSWIRE) - Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, today reported financial results for the second quarter and year-to |
|
| August 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): August 15, 2023 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission Fil |
|
| August 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-40785 ASS |
|
| August 8, 2023 |
Exhibit 99.1 7887 E. Belleview Ave. Suite 500 Denver, CO 80111 (720) 287-3093 Assure Holdings Acquires Certain Assets of Innovation Neuromonitoring, LLC Expects to Increase Annual Number of Cases by More than 3,000 DENVER, August 3, 2023 (GLOBE NEWSWIRE) - Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology se |
|
| August 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 2, 2023 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission File |
|
| August 8, 2023 |
Exhibit 10.2 NOMINEE AGREEMENT This Nominee Agreement (this “Agreement”) is effective as of August 2, 2023 (the “Effective Date”) by and between Innovation Neuromonitoring LLC (“Nominee”), and Assure Networks Texas Holdings II, LLC (“Beneficial Owner”). Nominee and the Beneficial Owner may be referred to individually as “Party” or collectively as “Parties” to this Agreement. RECITALS WHEREAS, the |
|
| August 8, 2023 |
Exhibit 99.1 ASSET PURCHASE AGREEMENT Assure Networks Texas Holdings II, LLC, a Colorado limited liability company (“Purchaser”), Innovation Neuromonitoring LLC (the “Seller”), and each of Anthony Casarez and Jason Ehrhardt (each a “Principal” and collectively, the “Principals”), enter into this Asset Purchase Agreement (this “Agreement”) dated August 2, 2023 (the “Effective Date”). RECITALS A. Se |
|
| July 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): July 25, 2023 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission File |
|
| June 29, 2023 |
Letter of Intent with Innovation Exhibit 10.1 June 22, 2023 Anthony Casarez CNIM President Innovation Neuromonitoring LLC Dear Mr. Casarez, By means of this Letter of Intent (this “LOI”), Assure Holdings Corp. (“AHC”), on behalf of its to be formed subsidiary (“Purchaser”) wishes to express its interest to purchase the assets (the “Transaction”) of Innovation Neuromonitoring LLC, (“Innovation”). Innovation and Purchaser may each |
|
| June 29, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): June 23, 2023 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission File |
|
| June 21, 2023 |
Amendment No. 1 to Non-Transferable Warrants dated June 14, 2023 Exhibit 4.1 AMENDMENT NO. 1 TO NON-TRANSFERABLE WARRANTS TO PURCHASE COMMON SHARES OF ASSURE HOLDINGS CORP. This Amendment Number One (“Amendment One”) to the Non-Transferable Warrants to Purchase Common Shares of Assure Holdings Corp. (the “Corporation”) issued to Centurion Financial Trust (the “Warrantholder”) on June 14, 2021 and represented by Certificate WC-US-2021-001 (the “Original Warrant” |
|
| June 21, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): June 14, 2023 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission File |
|
| May 16, 2023 |
ASSURE HOLDINGS CORP. ANNOUNCES CLOSING OF $6 MILLION UNDERWRITTEN PUBLIC OFFERING Exhibit 99.1 ASSURE HOLDINGS CORP. ANNOUNCES CLOSING OF $6 MILLION UNDERWRITTEN PUBLIC OFFERING DENVER, COLORADO, May 16, 2023 (GLOBE NEWSWIRE) - Assure Holdings Corp. (NASDAQ: IONM) (“Assure Holdings” or the “Company”), a provider of intraoperative neuromonitoring and remote neurology services, today announced the closing of an underwritten public offering of 5,000,000 shares of its common stock |
|
| May 16, 2023 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): May 16, 2023 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission File N |
|
| May 15, 2023 |
Table of Contents Filed Pursuant to Rule 424(b)(4) Registration No. 333-269438 ASSURE HOLDINGS CORP. 4,250,000 Shares of Common Stock 750,000 Pre-Funded Warrants to Purchase Common Stock Shares of Common Stock Underlying the Pre-Funded Warrants We are offering 4,250,000 shares of our common stock at an offering price of $1.20 per share. We are also offering 750,000 pre-funded warrants to those pur |
|
| May 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-40785 AS |
|
| May 12, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 (Post-Effective Amendment No. 1) REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ASSURE HOLDINGS CORP. (Exact Name of Registrant as Specified in its Charter) Nevada 809913 82-2726719 (State or other jurisdiction of incorporation or organization) Primary Standard Industrial Classification Code Number) (I.R.S. E |
|
| May 12, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): May 12, 2023 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission File N |
|
| May 12, 2023 |
Assure Holdings Sets First Quarter 2023 Conference Call for Tuesday, May 16, 2023, at 4:30 p.m. ET Exhibit 99.1 7887 E. Belleview Ave. Suite 500 Denver, CO 80111 (720)287-3093 Assure Holdings Sets First Quarter 2023 Conference Call for Tuesday, May 16, 2023, at 4:30 p.m. ET DENVER, May 12, 2023 (GLOBE NEWSWIRE) - Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, will hold a conference call on Tu |
|
| May 12, 2023 |
EX-1.1 2 tm2315620d1ex1-1.htm EXHIBIT 1.1 Exhibit 1.1 ASSURE HOLDINGS CORP. UNDERWRITING AGREEMENT May 11, 2023 Joseph Gunnar & Co., LLC 30 Broad Street, 11th Floor New York, NY 10004 Representative of the Underwriters As named on Schedule I hereto Ladies and Gentlemen: The undersigned, Assure Holdings Corp., a Nevada corporation (the “Company”), hereby confirms its agreement (this “Agreement”) to |
|
| May 12, 2023 |
Exhibit 4.2 Form of Representative Warrant Agreement THE REGISTERED HOLDER OF THIS COMMON STOCK PURCHASE WARRANT BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER, OR ASSIGN THIS COMMON STOCK PURCHASE WARRANT EXCEPT AS HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS COMMON STOCK PURCHASE WARRANT AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE, OR HYPOTHECATE THIS COMMON STO |
|
| May 12, 2023 |
ASSURE HOLDINGS CORP. ANNOUNCES PRICING OF $6 MILLION UNDERWRITTEN PUBLIC OFFERING Exhibit 99.1 ASSURE HOLDINGS CORP. ANNOUNCES PRICING OF $6 MILLION UNDERWRITTEN PUBLIC OFFERING DENVER, COLORADO, May 12, 2023 (GLOBE NEWSWIRE) - Assure Holdings Corp. (NASDAQ: IONM) (“Assure Holdings” or the “Company”), a provider of intraoperative neuromonitoring and remote neurology services, today announced the pricing of an underwritten public offering of 5,000,000 shares of its common stock |
|
| May 12, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): May 11, 2023 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission File N |
|
| May 10, 2023 |
Exhibit 4.2 Form of Representative Warrant Agreement NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOL |
|
| May 10, 2023 |
Assure Holdings Reports Preliminary First Quarter 2023 Financial Results Exhibit 99.1 7887 E. Belleview Ave. Suite 500 Denver, CO 80111 (720)287-3093 Assure Holdings Reports Preliminary First Quarter 2023 Financial Results DENVER, COLORADO, May 10, 2023 (GLOBE NEWSWIRE) - Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, today reported its preliminary financial results |
|
| May 10, 2023 |
ASSURE HOLDINGS CORP. 7887 East Belleview Avenue, Suite 500 Greenwood Village, Colorado 80111 May 10, 2023 Via EDGAR Securities and Exchange Commission 100 F Street, NE Washington, D.C. 20549 Re: Assure Holdings Corp. – Request for Acceleration Registration Statement on Form S-1 Filed on January 27, 2023, Amended May 2, 2023 and May 10, 2023 File No. 333-269438 Ladies and Gentlemen: On behalf of A |
|
| May 10, 2023 |
Joseph Gunnar & Co., LLC 30 Broad Street, 11th Floor New York, NY 10004 Tel: 212.440.9600 Joseph Gunnar & Co., LLC 30 Broad Street, 11th Floor New York, NY 10004 Tel: 212.440.9600 May 10, 2023 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F. Street, N.E. Washington, D.C. 20549 Re: Assure Holdings Corp. (the “Company”) Registration Statement on Form S-1 (File No. 333- 269438) REQUEST FOR ACCELERATION OF EFFECTIVENESS Ladies and Gentlemen: In accordance |
|
| May 10, 2023 |
Calculation of Filing Fee Table Exhibit 107 Calculation of Filing Fee Table Form S-1 (Form Type) ASSURE HOLDINGS CORP. |
|
| May 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): May 10, 2023 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission File N |
|
| May 10, 2023 |
As filed with the Securities and Exchange Commission on May 10, 2023 Table of Contents As filed with the Securities and Exchange Commission on May 10, 2023 Registration No. |
|
| May 2, 2023 |
Form of Representative Warrant Exhibit 4.2 Form of Representative Warrant Agreement NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOL |
|
| May 2, 2023 |
Calculation of Filing Fee Table Exhibit 107 Calculation of Filing Fee Table Form S-1 (Form Type) ASSURE HOLDINGS CORP. |
|
| May 2, 2023 |
Exhibit 10.31 Form of Lock-Up Agreement LOCK-UP AGREEMENT [] [], 2023 Joseph Gunnar & Co., LLC 30 Broad St. New York, NY 10004 Re: Assure Holdings Corp.—Public Offering Ladies and Gentlemen: The undersigned, an officer, director, and/or holder of common stock, par value $0.001 per share (the “Common Stock”), or rights to acquire shares of Common Stock (the “Shares”), of Assure Holdings Corp., a Ne |
|
| May 2, 2023 |
EX-4.1 3 ionm-20220930xex4d1.htm EX-4.1 Exhibit 4.1 PRE-FUNDED COMMON STOCK PURCHASE WARRANT ASSURE HOLDINGS CORP. Warrant Shares:[ ] Initial Exercise Date: THIS PREFUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [PURCHASER] or its assigns (the Holder) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set |
|
| May 2, 2023 |
As filed with the Securities and Exchange Commission on May 2, 2023 Table of Contents As filed with the Securities and Exchange Commission on May 2, 2023 Registration No. |
|
| May 2, 2023 |
Form of Underwriting Agreement Exhibit 1.1 ASSURE HOLDINGS CORP. UNDERWRITING AGREEMENT [] [], 2023 Joseph Gunnar & Co., LLC 30 Broad Street, 11th Floor New York, NY 10004 Representative of the Underwriters As named on Schedule I hereto Ladies and Gentlemen: The undersigned, Assure Holdings Corp., a Nevada corporation (the “Company”), hereby confirms its agreement (this “Agreement”) to issue and sell to the underwriter or under |
|
| April 28, 2023 |
Auditor Letter, dated April 28, 2023 Exhibit 16.1 April 28, 2023 Securities and Exchange Commission 100 F Street, NE Washington, DC 20549 Dear Ladies and Gentlemen: We are the independent registered public accounting firm for Assure Holdings Corp. (the “Company”). We have read the Company’s disclosure set forth in Item 4.01 “Changes in Registrant’s Certifying Accountant” of the Company’s Current Report on Form 8-K dated April 14, 202 |
|
| April 28, 2023 |
Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): April 11, 2023 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission Fi |
|
| April 17, 2023 |
As filed with the Securities and Exchange Commission on April 14, 2023 Table of Contents As filed with the Securities and Exchange Commission on April 14, 2023 Registration No. |
|
| April 17, 2023 |
Calculation of Filing Fee Table Exhibit 107 Calculation of Filing Fee Table Form S-1 (Form Type) ASSURE HOLDINGS CORP. |
|
| April 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): April 11, 2023 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission File |
|
| April 3, 2023 |
Exhibit 99.1 7887 E. Belleview Ave. Suite 500 Denver, CO 80111 (720)287-3093 Assure Holdings Reports 2022 Year End Financial Results DENVER, April 3, 2023 (GLOBE NEWSWIRE) - Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, today reported financial results for the full year ended December 31, 2022. |
|
| April 3, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): April 3, 2023 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission File |
|
| April 3, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): March 31, 2023 Assure Holdings Corp. (Exact name of registrant as specified in its charter) Nevada 001-40785 82-2726719 (State or other jurisdiction of incorporation) (Commission File |
|
| April 3, 2023 |
Exhibit 99.1 7887 E. Belleview Ave. Suite 500 Denver, CO 80111 (720)287-3093 Assure Holdings Sets Fourth Quarter and Year End 2022 Conference Call for Monday, April 3, 2023, at 9:00 a.m. ET DENVER, March 31, 2023 (GLOBE NEWSWIRE) - Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, will hold a confe |
|
| March 31, 2023 |
2020 Amended Equity Incentive Plan Exhibit 10.6 ASSURE HOLDINGS CORP. EQUITY INCENTIVE PLAN APPROVED BY THE SHAREHOLDERS AND ADOPTED BY THE BOARD OF DIRECTORS ON DECEMBER 10, 2020 AS AMENDED BY THE BOARD ON NOVEMBER 4, 2021 AND APPROVED BY SHAREHOLDERS ON DECEMBER 9, 2021 ASSURE HOLDINGS CORP. EQUITY INCENTIVE PLAN Section 1 - Purpose; Eligibility 1.1 General Purpose. The name of this plan is the Assure Holdings Corp. Equity Incent |
|
| March 31, 2023 |
SUBSIDIARIES SUBSIDIARIES Legal Name Jurisdiction Ownership Assure Holdings Corp. - Subsidiaries Assure Holdings, Inc. Colorado 100% Assure Holdings, Inc. - Subsidiaries Assure Neuromonitoring LLC Colorado 100% Assure Networks, LLC Colorado 100% Assure Equipment Leasing, LLC Colorado 100% Velocity Revenue Cycle, LLC Colorado 100% Assure Telehealth Providers, LLC Colorado 100% Assure Neuromonitorin |
|
| March 31, 2023 |
Amended 2020 Stock Option Plan Exhibit 10.5 ASSURE HOLDINGS CORP. STOCK OPTION PLAN APPROVED BY THE SHAREHOLDERS AND ADOPTED BY THE BOARD OF DIRECTORS ON DECEMBER 10, 2020 AS AMENDED BY THE BOARD OF DIRECTORS ON NOVEMBER 4, 2021, AND APPROVED BY THE SHAREHOLDERS ON DECEMBER 9, 2021 B-1 PART 1 INTERPRETATION 1.1 Defined Terms. For the purposes of this Plan, the following terms shall have the following meanings: “Administrator” h |
|
| March 31, 2023 |
DESCRIPTION OF SECURITIES Authorized Capital Stock Our authorized capital stock consists of 9,000,000 shares of common stock, par value $0. |
|
| March 31, 2023 |
Offer Letter between Assure Holdings Corp. and John Price dated November 16, 2020 EX-10.7 6 ionm-20221231xex10d7.htm EX-10.7 November 16, 2020 Mr. John Price RE: Offer of Employment Dear John Price: We are pleased to provide compensation and benefit information that will confirm our employment offer to you with Assure Holding's Corp (Assure). This confidential written offer letter contains an overview of both company and employee paid benefits. ANTICIPATED HIRE DATE: JOB TITLE: |
|
| March 31, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-40785 ASSURE |
